Back to Search
ANDERSEN GRIGG, DO
DO
Diagnostic Radiology Physician
NPI: 1437467354IndividualAccepts Medicare
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
R1686(KY)
CMS Specialties
PrimaryINTERVENTIONAL RADIOLOGY
Education
MID WEST MEDICAL COLLEGE
Class of 2007
Research & Publications (20)
Mycobacterium genavense duodenitis following allogeneic peripheral blood stem cell transplantation.
PMID 19656345·Transpl Infect Dis·2009
5-case
The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia.
PMID 19641525·Leukemia·2009
8-other
Thrombotic thrombocytopenic purpura is associated with a high relapse rate after plasma exchange: a single-centre experience.
PMID 18422566·Intern Med J·2009
8-other
Surgical management of invasive pulmonary fungal infection in hematology patients.
PMID 19379899·Ann Thorac Surg·2009
8-other
Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
PMID 18342947·J Infect·2008
8-other
A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease.
PMID 18621929·Blood·2008
3-trial
Antifungal prophylaxis in adult stem cell transplantation and haematological malignancy.
PMID 18588520·Intern Med J·2008
6-review
Breakthrough disseminated Scedosporium prolificans infection in a patient with relapsed leukaemia on prolonged voriconazole followed by posaconazole prophylaxis.
PMID 18512130·Mycopathologia·2008
5-case
Long-term toxicity of allogeneic stem cell transplantation in fludarabine-refractory chronic lymphocytic leukemia.
PMID 18464108·Leuk Lymphoma·2008
8-other
Cyclosporin, methotrexate and prednisolone for graft-versus-host disease prophylaxis in allogeneic peripheral blood progenitor cell transplants.
PMID 18176619·Bone Marrow Transplant·2008
3-trial
A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma.
PMID 17906297·Ann Oncol·2008
3-trial
Does initial spacing influence crown and hydraulic architecture of Eucalyptus marginata?
PMID 18316307·Tree Physiol·2008
8-other
Abbreviated dose rituximab for immune-mediated hematological disorders.
PMID 18314916·Am J Hematol·2008
8-other
A >or=1 log rise in RQ-PCR transcript levels defines molecular relapse in core binding factor acute myeloid leukemia and predicts subsequent morphologic relapse.
PMID 18297529·Leuk Lymphoma·2008
8-other
A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma.
PMID 18464112·Leuk Lymphoma·2008
3-trial
Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy.
PMID 18768781·Blood·2008
3-trial
A multicenter phase 2 study of risk-adjusted salvage chemotherapy incorporating vinorelbine and gemcitabine for relapsed and refractory lymphoma.
PMID 18932253·Cancer·2008
3-trial
Minimizing the risk of recurrent or progressive invasive mold infections during stem cell transplantation or further intensive chemotherapy.
PMID 17605732·Transpl Infect Dis·2008
6-review
Measurement of in vivo BCR-ABL kinase inhibition to monitor imatinib-induced target blockade and predict response in chronic myeloid leukemia.
PMID 17906206·J Clin Oncol·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- UNIVERSITY OF KENTUCKY AND AFFILIATES, 800 ROSE ST.
LEXINGTON, KY 40536 - Phone
- (859) 332-5000
Quick Facts
- NPI
- 1437467354
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 19
- Publications
- 20
Are you this provider?
Claim Your Profile